Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to evaluate the efficacy, safety, and pharmacoeconomics of escitalopram and an active comparator in patients with major depressive disorder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
240
Southwest Health, Ltd.
Phoenix, Arizona, United States
Summit Research Network
Okemos, Michigan, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Summit Research Network
Montgomery Asberg Depression Rating Scale (MADRS)
Hamilton Depression Rating Scale (HAMD)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Portland, Oregon, United States
CNS Research Institute
Philadelphia, Pennsylvania, United States
Clinical Neuroscience Solutions
Memphis, Tennessee, United States
Radiant Research
Salt Lake City, Utah, United States
Northwest Clinical Research Center
Bellevue, Washington, United States
Summit Research Network
Seattle, Washington, United States